Patents by Inventor Jeanette Elizabeth Langstone

Jeanette Elizabeth Langstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-interleukin-13 antibody compositions
    Patent number: 10358488
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: July 23, 2019
    Assignee: MEDIMMUNE LIMITED
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormick Fish, Jeanette Elizabeth Langstone
  • METHODS OF PURIFYING ANTI-INTERLEUKIN-13 ANTIBODIES
    Publication number: 20160002327
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Application
    Filed: July 14, 2015
    Publication date: January 7, 2016
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormick Fish, Jeanette Elizabeth Langstone
  • Methods of purifying anti-interleukin-13 antibodies
    Patent number: 9107945
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: August 18, 2015
    Assignee: MedImmune Limited
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormick Fish, Jeanette Elizabeth Langstone
  • Interleukin-13 Antibody Composition
    Publication number: 20110086038
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Application
    Filed: December 13, 2010
    Publication date: April 14, 2011
    Applicant: Medlmmune Limited
    Inventors: Claire Louise Hope, Karen Bannister, Brendan Cormack Fish, Jeanette Elizabeth Langstone
  • Interleukin-13 Antibody Composition
    Publication number: 20080248048
    Abstract: The invention relates to a pharmaceutical composition comprising an interleukin-13 antibody, more particularly a monoclonal interleukin-13 antibody, especially a human interleukin-13 monoclonal antibody, to a process for purifying said antibody and to the use of said composition in treating interleukin-13 related disorders, such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, chronic obstructive pulmonary disease, scleroderma, inflammatory bowel disease and Hodgkin's lymphoma, particularly asthma.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 9, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Brendan Cormick Fish, Jeanette Elizabeth Langstone, Karen Bannister, Claire Louise Hope